🟢 XBI is trading 3% up today as biotech shares extend recent momentum

XBI is trading 3.02% up now at $169.13 as biotech shares extend recent momentum amid positive sector sentiment.

• The broader market is also modestly higher ahead of inflation data and major technology earnings.
• Investor confidence has been supported by Moderna and Merck’s successful late-stage personalized mRNA melanoma-vaccine trial, the first positive Phase 3 result for an mRNA cancer therapy.
• No XBI-specific announcement was identified.